This inventor holds 4 USPTO granted patents and 2 published patent applications and 1 EPO patent. Top assignees: Baxter Healthcare Sa, Baxter International Inc.. Active years: 2008-2015.
Location History:
- Los Angeles, CA (US) (2008)
- Lake Geneva, WI (US) (2010 - 2015)
Company Filing History:
4 out of 1,198 
4 out of 2,530 
Years Active: 2008-2015
Title: Shane Donovan - Innovator in Fibrin Gel Technology
Introduction
Shane Donovan is a notable inventor based in Lake Geneva, WI (US). He has made significant contributions to the field of medical technology, particularly in the development of fibrin gel for therapeutic applications. With a total of 4 patents, Donovan's work focuses on enhancing treatment options for various medical conditions.
Latest Patents
One of Shane Donovan's latest patents is titled "Fibrin gel for controlled release of PDGF and uses thereof." This invention relates to fibrin sealants that incorporate platelet-derived growth factor (PDGF) for controlled release in situ. The therapeutic applications of this invention include treatment for musculoskeletal disorders, soft tissue disorders, and vascular diseases. This innovative approach aims to improve patient outcomes through targeted delivery of growth factors.
Career Highlights
Throughout his career, Shane Donovan has worked with prominent companies in the medical field, including Baxter International Inc. and Baxter Healthcare. His experience in these organizations has allowed him to develop and refine his inventions, contributing to advancements in medical treatments.
Collaborations
Shane has collaborated with several professionals in his field, including Isabelle Catelas and Sam L Helgerson. These collaborations have fostered a productive environment for innovation and development in medical technologies.
Conclusion
Shane Donovan's work in fibrin gel technology exemplifies the impact of innovation in the medical field. His patents and collaborations highlight his commitment to improving therapeutic options for patients.